Human Herpesvirus 6 Detection in Alzheimer’s Disease Cases and Controls across Multiple Cohorts DOI Creative Commons
Mary Alice Allnutt, Kory Johnson, David A. Bennett

et al.

Neuron, Journal Year: 2020, Volume and Issue: 105(6), P. 1027 - 1035.e2

Published: Jan. 23, 2020

Language: Английский

Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease DOI Open Access

Deepak Kumar Vijaya Kumar,

Se Hoon Choi,

Kevin J. Washicosky

et al.

Science Translational Medicine, Journal Year: 2016, Volume and Issue: 8(340)

Published: May 25, 2016

β-Amyloid protein oligomerization and fibrillization, known to be pathogenic in Alzheimer’s disease, may play a physiological role microbial entrapment innate immunity.

Language: Английский

Citations

865

Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection DOI Creative Commons
William A. Eimer,

Deepak Kumar Vijaya Kumar,

Nanda Kumar N. Shanmugam

et al.

Neuron, Journal Year: 2018, Volume and Issue: 99(1), P. 56 - 63.e3

Published: July 1, 2018

Language: Английский

Citations

564

Microbes and Alzheimer’s Disease DOI Open Access
Ruth F. Itzhaki, Richard Lathe, Brian J. Balin

et al.

Journal of Alzheimer s Disease, Journal Year: 2016, Volume and Issue: 51(4), P. 979 - 984

Published: April 12, 2016

We are researchers and clinicians working on Alzheimer’s disease (AD) or related topics, we write to express our concern that one particular aspect of the has been neglected, even thoug ...

Language: Английский

Citations

465

Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future DOI Creative Commons
Yun Zhang, Huaqiu Chen, Ran Li

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: June 30, 2023

Abstract Amyloid β protein (Aβ) is the main component of neuritic plaques in Alzheimer’s disease (AD), and its accumulation has been considered as molecular driver pathogenesis progression. Aβ prime target for development AD therapy. However, repeated failures Aβ-targeted clinical trials have cast considerable doubt on amyloid cascade hypothesis whether drug followed correct course. recent successes targeted assuaged those doubts. In this review, we discussed evolution over last 30 years summarized application diagnosis modification. particular, extensively pitfalls, promises important unanswered questions regarding current anti-Aβ therapy, well strategies further study more feasible approaches optimization prevention treatment.

Language: Английский

Citations

410

The antimicrobial protection hypothesis of Alzheimer's disease DOI Creative Commons
Robert D. Moir, Richard Lathe, Rudolph E. Tanzi

et al.

Alzheimer s & Dementia, Journal Year: 2018, Volume and Issue: 14(12), P. 1602 - 1614

Published: Oct. 9, 2018

Abstract Objective We explore here a novel model for amyloidogenesis in Alzheimer's disease (AD). This new perspective on AD amyloidosis seeks to provide rational framework incorporating recent and seemingly independent findings the antimicrobial role of β‐amyloid emerging experimental, genetic, epidemiological data, suggesting innate immune‐mediated inflammation propagates neurodegeneration. Background pathology is characterized by cerebral deposition amyloid‐β protein (Aβ) as β‐amyloid. Genetic studies have confirmed key Aβ AD, revealing that mutation‐mediated shifts peptides generation lead early onset familial disease. However, appears normal majority patients, who lack mutations. In prevailing models nonfamilial individual genetics age‐associated changes brain milieu promote an intrinsically abnormal propensity self‐association. are increasingly inconsistent with characterization oligomerization nonphysiological exclusively pathological activity. Recent suggest ancient, highly conserved effector molecule immunity. Moreover, appear be important immune pathways mediate pathogen entrapment protect against infection. New inflammation‐mediated neurodegeneration immunity led emergence “Antimicrobial Protection Hypothesis” AD. this model, response genuine, or mistakenly perceived, immunochallenge. first entraps neutralizes invading pathogens fibrillization drives neuroinflammatory help fight infection clear β‐amyloid/pathogen deposits. chronic activation pathway leads sustained Mounting data link elevated microbe levels The Antimicrobial Hypothesis reveals how increased microbial burden may directly exacerbate deposition, inflammation, progression. Amyloid cascade hypothesis protection modality Aβ's pathophysiology shifted from stochastic behavior toward dysregulated response. still Thus, extends but remains broadly consistent Cascade overwhelming showing primacy pathology.

Language: Английский

Citations

378

Self-assembling dipeptide antibacterial nanostructures with membrane disrupting activity DOI Creative Commons
Lee Schnaider, Sayanti Brahmachari, Nathan W. Schmidt

et al.

Nature Communications, Journal Year: 2017, Volume and Issue: 8(1)

Published: Nov. 3, 2017

Abstract Peptide-based supramolecular assemblies are a promising class of nanomaterials with important biomedical applications, specifically in drug delivery and tissue regeneration. However, the intrinsic antibacterial capabilities these have been largely overlooked. The recent identification common characteristics shared by self-assembling peptides provides paradigm shift towards development agents. Here we present activity self-assembled diphenylalanine, which emerges as minimal model for polymers. diphenylalanine nano-assemblies completely inhibit bacterial growth, trigger upregulation stress-response regulons, induce substantial disruption to morphology, cause membrane permeation depolarization. We demonstrate specificity interactions materials integration peptide into scaffolds. This study insights significance interplay between self-assembly antimicrobial establishes innovative design principles toward agents materials.

Language: Английский

Citations

365

The role of astrocytes in amyloid production and Alzheimer's disease DOI Creative Commons
Georgia Frost,

Yue‐Ming Li

Open Biology, Journal Year: 2017, Volume and Issue: 7(12), P. 170228 - 170228

Published: Dec. 1, 2017

Alzheimer's disease (AD) is marked by the presence of extracellular amyloid beta (Aβ) plaques, intracellular neurofibrillary tangles (NFTs) and gliosis, activated glial cells, in brain. It thought that Aβ plaques trigger NFT formation, neuronal cell death, neuroinflammation gliosis and, ultimately, cognitive impairment. There are increased numbers reactive astrocytes AD, which surround secrete proinflammatory factors can phagocytize break down Aβ. was cells were major source However, mounting evidence suggests may play an additional role AD secreting significant quantities contributing to overall burden Astrocytes most numerous type brain, therefore even minor secretion from individual could prove be substantial when taken across whole Reactive have levels three necessary components for production: precursor protein, β-secretase (BACE1) γ-secretase. The identification environmental factors, such as neuroinflammation, promote astrocytic production, redefine how we think about developing therapeutics AD.

Language: Английский

Citations

347

The Infectious Etiology of Alzheimer’s Disease DOI
Marta Sochocka, Katarzyna Zwolińska, Jerzy Leszek

et al.

Current Neuropharmacology, Journal Year: 2017, Volume and Issue: 15(7)

Published: March 15, 2017

Inflammation is a part of the first line defense body against invasive pathogens, and plays crucial role in tissue regeneration repair. A proper inflammatory response ensures suitable resolution inflammation elimination harmful stimuli, but when reactions are inappropriate it can lead to damage surrounding normal cells. The relationship between infections Alzheimer's Disease (AD) etiology, especially lateonset AD (LOAD) has been continuously debated over past three decades.This review discusses whether could be causative factor that promotes progression summarizes recent investigations associating infectious agents chronic with AD. Preventive therapeutic approaches context an etiology disease also discussed.Emerging evidence supports hypothesis neurotropic viruses from Herpesviridae family, Human herpesvirus 1 (HHV-1), Cytomegalovirus (CMV), 2 (HHV-2), neuropathology. Recent indicate association Hepatitis C virus (HCV) infection dementia. Among bacteria special attention focused on spirochetes family periodontal pathogens such as Porphyromonas gingivalis or Treponema denticola cause periodontitis possibly contribute clinical onset AD.Chronic viral, bacterial fungal might factors for pathway

Language: Английский

Citations

340

The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease DOI Creative Commons
Holly M. Brothers, Maya L. Gosztyla, Stephen R. Robinson

et al.

Frontiers in Aging Neuroscience, Journal Year: 2018, Volume and Issue: 10

Published: April 25, 2018

Amyloid-ß (Aß) is best known as the misfolded peptide that involved in pathogenesis of Alzheimer's disease (AD), and it currently primary therapeutic target attempts to arrest course this disease. This notoriety has overshadowed evidence Aß serves several important physiological functions. present throughout lifespan, been found all vertebrates examined thus far, its molecular sequence shows a high degree conservation. These features are typical factor contributes significantly biological fitness, suggestion supported by functions beneficial for brain. The putative roles include protecting body from infections, repairing leaks blood-brain barrier, promoting recovery injury, regulating synaptic function. Evidence these comes vitro vivo studies, which have shown cellular production rapidly increases response challenge often diminishes upon recovery. further adverse outcomes clinical trials attempted deplete order treat AD. We suggest anti-Aß therapies will produce fewer effects if triggers deposition (e.g. pathogens, hypertension diabetes) addressed first.

Language: Английский

Citations

264

Periodontal disease associates with higher brain amyloid load in normal elderly DOI
Angela R. Kamer, Elizabeth Pirraglia, Wai Tsui

et al.

Neurobiology of Aging, Journal Year: 2014, Volume and Issue: 36(2), P. 627 - 633

Published: Nov. 5, 2014

Language: Английский

Citations

225